Home
>
National Drug Code (NDC)
>
Triostat
Triostat - 42023-120-06 - (liothyronine sodium)
Drug Information of Triostat
| Product NDC: | 42023-120 |
| Proprietary Name: | Triostat |
| Non Proprietary Name: | liothyronine sodium |
| Active Ingredient(s): | 10 ug/mL & nbsp; liothyronine sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Triostat
| Product NDC: | 42023-120 |
| Labeler Name: | JHP Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020105 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071001 |
Package Information of Triostat
| Package NDC: | 42023-120-06 |
| Package Description: | 6 VIAL in 1 CARTON (42023-120-06) > 1 mL in 1 VIAL |
NDC Information of Triostat
| NDC Code | 42023-120-06 |
| Proprietary Name | Triostat |
| Package Description | 6 VIAL in 1 CARTON (42023-120-06) > 1 mL in 1 VIAL |
| Product NDC | 42023-120 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | liothyronine sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20071001 |
| Marketing Category Name | NDA |
| Labeler Name | JHP Pharmaceuticals LLC |
| Substance Name | LIOTHYRONINE SODIUM |
| Strength Number | 10 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
